Clinical Trial Update: A Study of K-645 in the Treatment of Multiple Migraine Attacks [Phase 2]

View source ↗

Summary

A Phase 2 study of K-645 for the treatment of multiple migraine attacks has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• K-645

Snippet

Sponsor: Kallyope Inc. | Conditions: Acute Migraine | Phase 2 | Status: TERMINATED